Arena Pharma (ARNA) Tops Q1 EPS by 8068c

Arena Pharma (NASDAQ: ARNA) reported Q1 EPS of $80.00, $80.68 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $2.76 million.

For earnings history and earnings-related data on Arena Pharma (ARNA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance